South Florida Hospital News
Sunday May 1, 2016
Quote

test 2

April 2016 - Volume 12 - Issue 10

Subscribe

Advertisements

test
http://cme.baptisthealth.net/pfs/pages/index.aspx
advertizehere.gif
EmedmalSmall.JPG

Broward Health North’s Clinical Lab and Blood Gas Lab had an outstanding College of American Pathology (CAP) survey. A Team of 8 CAP inspectors came from Baptist Healthcare to inspect documentation for quality control standards, process improvement outcomes, procedure manuals and non-waived point of care testing. The surveyors reviewed the areas of Hematology, Coagulation, Chemistry, Blood Bank, Histology, General Lab, Urinalysis and Blood Gas Laboratory. Over 2500 CAP standards were reviewed.

The inspectors praised BHN for an outstanding job with detailed documentation and organizational excellence while fulfilling several new CAP standards. They were very impressed with our accomplishments while maintaining lean staffing. CAP onsite survey is held every 2 years. 

After undergoing an on-site evaluation and demonstrating compliance with nationally developed standards for stroke care, Broward Health North (BHN) has earned The Joint Commission’s Gold Seal of Approval™ for certification as a Primary Stroke Center, Stroke Rehabilitation, Hip and Knee Joint Replacement, Alzheimer’s disease as well as certification for Spine . According to The Joint Commission standards, BHN provides the next generation of care to patients.

“BHN strives to provide our patients with the best care, and this recertification furthers our goal of five-star health care. All six of our programs were re-certified without any recommendations for improvement,” said Pauline Grant, CEO of BHN. 

The Christine E. Lynn College of Nursing at Florida Atlantic University has received a ranking of No. 46 for its Master of Science Nursing (MSN) program and No. 44 for its Doctor of Nursing (DNP) program by the U.S. News & World Report 2017 Best Graduate Schools Guidebook. The College has quickly risen from its previous ranking of No. 72 for its master’s and doctoral programs in 2016, and this is the highest ranking for FAU’s graduate nursing programs in its 27-year history. 

FAU’s College of Nursing ranks third in the state of Florida for both its MSN and DNP programs. 

Ora Strickland, Ph.D., R.N., FAAN, dean of Florida International University (FIU) Nicole Wertheim College of Nursing & Health Sciences, is one of 19 nurse researchers being inducted into the 2016 class of the International Nurse Researcher Hall of Fame. Of the more than 16 million nurses worldwide, Dean Strickland now joins fewer than 100 nursing professionals to receive this prestigious honor since its inception.

“I am both humbled and honored by the recognition that comes with admission to the International Nurse Researcher Hall of Fame,” said Dean Strickland. “I appreciate being considered among such great leaders in the nursing profession whose work has contributed to tremendous achievements in improving patient care and advancement of the profession through evidence-based practices.”
 
 
 
The Boca Raton Chamber of Commerce has named Rosie and Joe Martin, Allegiance Home Health, as the 2016 Small Business Leaders of the Year. 

Hospital Corporation of America (HCA) has been recognized as a 2016 World’s Most Ethical Company® by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices. This is the seventh consecutive year HCA has been honored, underscoring its consistent commitment to ethical business standards and practices.

This year marks the tenth anniversary of Ethisphere and the World’s Most Ethical Companies designation which recognizes organizations that have had a material impact on the way business is conducted by fostering a culture of ethics and transparency at every level of the company.
The Application Review Committee (ARC) of the Miami Dade County Public Schools voted to approve the Larkin Middle School for the Health Sciences.
 
The ARC will now make a recommendation of approval of the charter school application to the Superintendent of Schools. The new middle school (grades 6th through 8th) is expected to open on August 2018 and will be tuition-free for Miami-Dade County residents. First year enrollment is expected to be up to 330 students with a maximum enrollment of up to 792 students. The school will be built at the hospital’s Health Sciences Campus, a 48-acre Campus located in Naranja Lakes, immediately accessible from US1 and SW 280th Street. It will cover 55,000 square feet and will be equipped with an estimated 30 classrooms, science labs, art room, music room, media center and a cafeteria/auditorium.
 
The proposed Larkin Health Sciences Campus in Naranja will boost the local economy by establishing a College of Pharmacy, a College of Medicine, a College of Dentistry and a School of Nursing, all anchored by the Larkin Charter Middle School for the Health Sciences.

Good Samaritan Medical Center’s new Cancer Genetics Program can help determine whether you are at risk for certain types of cancer. The program, led by Dr. Elisabeth McKeen, medical oncologist, and Conni Murphy, a nurse practitioner with specialized training in cancer genetics, consists of a genetic screening process and counseling sessions.

During your initial evaluation period, you will fill out a questionnaire, which includes questions regarding your personal and family history of cancer. The next step is genetic testing, which consists of a simple mouthwash or blood test. Analysis of the sample can determine if you inherited a gene mutation that may increase your cancer risk. However, it is important to remember that testing positive for a gene mutation is not a guarantee of developing cancer.
 
The results of genetic testing can help you make informed decisions about how to best manage your future healthcare. They may also assist your doctor in developing a personalized plan of care. For example, if it is determined that you are at risk for breast cancer, you may be advised to add breast MRIs to your routine screenings to aid in early detection.
 
The Lake Erie Consortium for Osteopathic Medical Training (LECOMT) and Larkin Community Hospital (LCH) recently announced approval from the American Osteopathic Association's (AOA) Program and Trainee Review Committee to start a new medical residency training program in Family Medicine.
The AOA granted the hospital approval to train 18 medical residents in Family Medicine.
 
The main training site for the Family Medicine Residency Program will be Larkin Community Hospital's recently acquired Palm Springs Campus, a 247-bed acute care hospital in Hialeah.
 
"We are delighted to partner with LCH to develop graduate medical education training to help alleviate the shortage of primary care physicians in South Florida and the United States," said Richard Terry, D.O., Chief Academic Officer of LECOMT.
Memorial Healthcare System’s (MHS) two Comprehensive Stroke Centers have been selected among 50 sites worldwide to participate in a major clinical trial designed to examine outcomes for patients presenting with stroke due to a large vessel occlusion (LVO).
 
Several large scale studies published in the New England Journal of Medicine last year ushered in a whole new era for stroke treatment with stentriever devices to remove blood clots in the brain. This type of therapy is called mechanical thrombectomy and it is now the standard of care in stroke patients with LVO who present to the hospital within the first 6 hours of symptom onset. Unfortunately, a significant number of stroke victims do not get to the hospital in time for these life-saving therapies.
The DAWN clinical trial is designed to evaluate an extended treatment time window for this targeted population of patients presenting with ischemic stroke. Research shows that 20-30% of stroke patients arrive to the hospital well beyond 6 hours from symptom onset. These patients are classified as late presenting strokes. Also included in this population are patients who experience symptoms during sleep and have no knowledge as to time of stroke onset. Such patients have limited treatment options available to them based on current American Stroke Association (ASA) guidelines and, as a result, suffer from long-term disability and poor quality of life.
 
The DAWN clinical trial will utilize advanced imaging technology known as RAPID CT Perfusion (CTP) to assess regions of the brain deprived of blood flow in patients with LVO. CTP has been shown to be useful in identifying patients who may benefit from aggressive treatment despite presenting in the later time windows after stroke onset. Eligible patients will be considered for the DAWN trial at the two flagship MHS comprehensive stroke centers located at Memorial Regional Hospital and Memorial Hospital West.
<< 21 thru 30 out of 35 >>
Share |